Discover
NAMS
NewAmsterdam Pharma Company N.V.
35.17
2 x 25.05
2 x 43.94
bid
ask
+
1.28
3.78%
2 @ 04:00 PM
35.17 +0.00 (0.00%)
| Ytd | 0.26% | |
| 1y | 93.03% |
34.06
day range
35.40
18.07
52 week range
42.20
| Open | 34.33 | Prev Close | 33.89 | Low | 34.06 | High | 35.40 | Mkt Cap | 4.11B |
| Vol | 867.67K | Avg Vol | 1.29M | EPS | -1.78 | P/E | N/A | Forward P/E | -27.63 |
| Beta | 0.08 | Short Ratio | 7.09 | Inst. Own | 106.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 32.68 | 200-d Avg | 33.56 | 1yr Est | 49.46 |
| Income Statement | |||
| Total Revenue | 3.04M | ||
| Revenues (USD) | 3.49M | ||
| Gross Profit | 3.04M | ||
| Operating Expenses | 61.46M | ||
| Research and Development Expense | 38.01M | ||
| Selling, General and Administrative Expense | 23.45M | ||
| Operating Income | -58.42M | ||
| Net Income | -48.44M | ||
| Net Income Common Stock | -48.44M | ||
| Net Income Common Stock (USD) | -55.68M | ||
| Consolidated Income | -48.44M | ||
| Earnings per Basic Share | -0.40 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.40 | ||
| Earning Before Interest & Taxes (EBIT) | -48.44M | ||
| Earning Before Interest & Taxes (USD) | -55.68M | ||
| Weighted Average Shares | 114.98M | ||
| Balance Sheet | |||
| Cash and Equivalents | 458.94M | ||
| Cash and Equivalents (USD) | 527.52M | ||
| Investments | 249.74M | ||
| Investments Current | 178.50M | ||
| Investments Non-Current | 71.24M | ||
| Trade and Non-Trade Receivables | 20.60M | ||
| Current Assets | 658.04M | ||
| Property, Plant & Equipment Net | 400.00K | ||
| Total Assets | 732.64M | ||
| Debt Current | 23.00K | ||
| Total Debt | 23.00K | ||
| Current Liabilities | 67.42M | ||
| Total Liabilities | 67.42M | ||
| Accumulated Retained Earnings (Deficit) | -810.83M | ||
| Accumulated Other Comprehensive Income | 4.22M | ||
| Shareholders Equity | 665.22M | ||
| Shareholders Equity (USD) | 764.62M | ||
| Assets Non-Current | 74.60M | ||
| Total Debt (USD) | 26.44K | ||
| Deferred Revenue | 3.99M | ||
| Goodwill and Intangible Assets | 375.00K | ||
| Trade and Non-Trade Payables | 8.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 62.00K | ||
| Net Cash Flow from Financing | 11.07M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -31.05M | ||
| Capital Expenditure | -38.00K | ||
| Issuance (Purchase) of Equity Shares | 11.07M | ||
| Net Cash Flow from Investing | -11.51M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -11.47M | ||
| Net Cash Flow from Operations | -30.60M | ||
| Share Based Compensation | 18.00M | ||